Individual 5-fluorouracile dose optimization in FOLFIRI treatment

Details for Australian Patent Application No. 2008362109 (hide)

Owner CENTRE REGIONAL DE LUTTE CONTRE LE CANCER D'ANGERS UNIVERSITE D'ANGERS

Inventors Gamelin, Erick; Boisdron-Celle, Michele; Morel, Alain

Agent Griffith Hack

Pub. Number AU-A-2008362109

PCT Pub. Number WO2010/035076

Filing date 26 September 2008

Wipo publication date 1 April 2010

International Classifications

A61K 31/4745 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 39/00 (2006.01) General protective or antinoxious agents

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/035076 Priority application(s): WO2010/035076

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008362112-Method and device for draining liquid coating metal at the output of a tempering metal coating tank

2008362108-Individual 5-fluorouracile dose optimization in FOLFOX treatment